Fig. 3
Alteration of cell proliferation by GSI IX treatment in the CC cell lines. The combination treatment of GSI IX and GEM significantly reduced viable RBE and TFK-1 cells compared with GEM monotherapy
Fig. 3 | BMC Cancer
Alteration of cell proliferation by GSI IX treatment in the CC cell lines. The combination treatment of GSI IX and GEM significantly reduced viable RBE and TFK-1 cells compared with GEM monotherapy